Twist Bioscience Corporation (TWST): Price and Financial Metrics
TWST Price/Volume Stats
| Current price | $46.95 | 52-week high | $60.90 |
| Prev. close | $44.57 | 52-week low | $14.42 |
| Day low | $45.12 | Volume | 710,800 |
| Day high | $47.23 | Avg. volume | 1,013,535 |
| 50-day MA | $47.78 | Dividend yield | N/A |
| 200-day MA | $40.11 | Market Cap | 2.73B |
TWST Stock Price Chart Interactive Chart >
Twist Bioscience Corporation (TWST) Company Bio
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as oligonucleotides, genes, pathways, chassis, and genomes. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
Latest TWST News From Around the Web
Below are the latest news stories about TWIST BIOSCIENCE CORP that investors may wish to consider to help them evaluate TWST as an investment opportunity.
Twist Bioscience launches human methylome panelTwist Bioscience (NASDAQ:TWST) on Tuesday announced the launch of its Human Methylome Panel, a product that can advance applications in cancer metastasis, human development and functional genetics. The company said its Twist Human Methylome Panel can also be used as a discovery tool to identify methylation biomarkers that can then be... |
TWST Price Returns
| 1-mo | 7.78% |
| 3-mo | -7.14% |
| 6-mo | 32.59% |
| 1-year | 124.11% |
| 3-year | -61.43% |
| 5-year | 57.50% |
| YTD | 27.37% |
| 2023 | 54.81% |
| 2022 | -69.23% |
| 2021 | -45.23% |
| 2020 | 572.81% |
| 2019 | -9.05% |
Loading social stream, please wait...